.After antibody-drug conjugate (ADC) professional Seagen was sold to Pfizer in 2015 for an immense $...
.On the heels of a stage 3 succeed that neglected to impress clients, Ironwood Pharmaceuticals is ba...
.Don't cease Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after signing a ...
.Invite to recently's Chutes & Ladders, our summary of substantial management hirings, firings an...
.Celebrating his business's upsized going public (IPO), Septerna chief executive officer Jeffrey Fin...
.AbbVie has returned to the source of its antipsychotic goliath Vraylar looking for one more runaway...
.GenSight Biologics is full weeks out of lacking loan. Again. The biotech only has adequate cash mon...
.Monopar Rehabs is bouncing back a medication coming from the scrap heap of AstraZeneca's uncommon c...
.With brand-new records out on Arcus Biosciences' experimental HIF-2a inhibitor, one team of analyst...
.After developing a gene therapy alliance with Dyno Therapies in 2020, Roche is back for additional....